GLOBAL BIOENERGIES TO PARTICIPATE AT 30TH ANNUAL ROTH CAPITAL CONFERENCE

            Global Bioenergies to Participate at 30th Annual ROTH Capital Conference

LOS ANGELES, CA and PARIS, France - March 5, 2018 - Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons through fermentation, will be participating at the 30th Annual ROTH Capital Conference. The conference is being held on March 11-14, 2018 at The Ritz-Carlton in Dana Point, CA.

Marc Delcourt, Chief Executive Officer will be conducting one-on-one meetings with investors and analysts at the conference on Monday and Tuesday, March 12-13.

Investors interested in arranging one-on-one meetings should contact your ROTH representative. Conversely, you may also call or email Lytham Partners at (602) 889-9700 or [email protected].

A copy of the slide presentation Global Bioenergies will be referencing during the conference will be available in the Investor Relations section of the company's website at www.globalbioenergies-invest.com.

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full-scale plant through a joint venture with Cristal Union, named IBN-One. Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 - ALGBE).

Stay informed! Subscribe to our newsfeed on
www.global-bioenergies.com

Follow us on Twitter: @GlobalBioenergi

Contact

GLOBAL BIOENERGIES
Jean-Baptiste Barbaroux
Chief Corporate Officer
Phone: +33 1 64 98 20 50
[email protected]

Attachment:

http://www.globenewswire.com/NewsRoom/AttachmentNg/2a4ce80f-495c-4360-a923-ca1e96ad5ee6